234 related articles for article (PubMed ID: 31127089)
21. Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients.
Bumb JM; Aksay SS; Janke C; Kranaster L; Geisel O; Gass P; Hellweg R; Sartorius A
Eur Arch Psychiatry Clin Neurosci; 2015 Apr; 265(3):227-32. PubMed ID: 25231834
[TBL] [Abstract][Full Text] [Related]
22. Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels.
Rapinesi C; Kotzalidis GD; Curto M; Serata D; Ferri VR; Scatena P; Carbonetti P; Napoletano F; Miele J; Scaccianoce S; Del Casale A; Nicoletti F; Angeletti G; Girardi P
Psychiatry Res; 2015 Jun; 227(2-3):171-8. PubMed ID: 25910420
[TBL] [Abstract][Full Text] [Related]
23. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
[TBL] [Abstract][Full Text] [Related]
24. BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression.
Viikki ML; Järventausta K; Leinonen E; Huuhka M; Mononen N; Lehtimäki T; Kampman O
Psychiatr Genet; 2013 Jun; 23(3):134-6. PubMed ID: 23532066
[TBL] [Abstract][Full Text] [Related]
25. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.
Piccinni A; Del Debbio A; Medda P; Bianchi C; Roncaglia I; Veltri A; Zanello S; Massimetti E; Origlia N; Domenici L; Marazziti D; Dell'Osso L
Eur Neuropsychopharmacol; 2009 May; 19(5):349-55. PubMed ID: 19223156
[TBL] [Abstract][Full Text] [Related]
26. Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder.
Huuhka K; Anttila S; Huuhka M; Leinonen E; Rontu R; Mattila K; Lehtimäki T
Eur Arch Psychiatry Clin Neurosci; 2007 Feb; 257(1):31-5. PubMed ID: 17036259
[TBL] [Abstract][Full Text] [Related]
27. Plasma BDNFs level initially and post treatment in acute mania: comparison between ECT and atypical antipsychotic treatment and healthy controls.
Karamustafalioglu N; Genc A; Kalelioglu T; Tasdemir A; Umut G; Incir S; Akkuş M; Emul M
J Psychopharmacol; 2015 Aug; 29(8):898-902. PubMed ID: 25827643
[TBL] [Abstract][Full Text] [Related]
28. Grey matter volume increase following electroconvulsive therapy in patients with late life depression: a longitudinal MRI study.
Bouckaert F; De Winter FL; Emsell L; Dols A; Rhebergen D; Wampers M; Sunaert S; Stek M; Sienaert P; Vandenbulcke M
J Psychiatry Neurosci; 2016 Mar; 41(2):105-14. PubMed ID: 26395813
[TBL] [Abstract][Full Text] [Related]
29. The ratio and interaction between neurotrophin and immune signaling during electroconvulsive therapy in late-life depression.
Loef D; Vansteelandt K; Oudega ML; van Eijndhoven P; Carlier A; van Exel E; Rhebergen D; Sienaert P; Vandenbulcke M; Bouckaert F; Dols A
Brain Behav Immun Health; 2021 Dec; 18():100389. PubMed ID: 34841285
[TBL] [Abstract][Full Text] [Related]
30. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.
Bocchio-Chiavetto L; Zanardini R; Bortolomasi M; Abate M; Segala M; Giacopuzzi M; Riva MA; Marchina E; Pasqualetti P; Perez J; Gennarelli M
Eur Neuropsychopharmacol; 2006 Dec; 16(8):620-4. PubMed ID: 16757154
[TBL] [Abstract][Full Text] [Related]
31. Differences in Cognitive Outcomes After ECT Depending on BDNF and COMT Polymorphisms.
Bennett DM; Currie J; Fernie G; Perrin JS; Reid IC
J ECT; 2016 Dec; 32(4):243-250. PubMed ID: 27191122
[TBL] [Abstract][Full Text] [Related]
32. Early- and Late-Onset Depression in Late Life: A Prospective Study on Clinical and Structural Brain Characteristics and Response to Electroconvulsive Therapy.
Dols A; Bouckaert F; Sienaert P; Rhebergen D; Vansteelandt K; Ten Kate M; de Winter FL; Comijs HC; Emsell L; Oudega ML; van Exel E; Schouws S; Obbels J; Wattjes M; Barkhof F; Eikelenboom P; Vandenbulcke M; Stek ML
Am J Geriatr Psychiatry; 2017 Feb; 25(2):178-189. PubMed ID: 27771245
[TBL] [Abstract][Full Text] [Related]
33. Electroconvulsive therapy response in late-life depression unaffected by age-related brain changes.
Bouckaert F; Emsell L; Vansteelandt K; De Winter FL; Van den Stock J; Obbels J; Dols A; Stek M; Adamczuk K; Sunaert S; Van Laere K; Sienaert P; Vandenbulcke M
J Affect Disord; 2019 May; 251():114-120. PubMed ID: 30921594
[TBL] [Abstract][Full Text] [Related]
34. Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy.
Bousman CA; Katalinic N; Martin DM; Smith DJ; Ingram A; Dowling N; Ng C; Loo CK
J ECT; 2015 Jun; 31(2):129-35. PubMed ID: 25148110
[TBL] [Abstract][Full Text] [Related]
35. Acute effects of a session of electroconvulsive therapy on brain-derived neurotrophic factor plasma levels.
Bioque M; Mac-Dowell KS; Font C; Meseguer A; Macau E; Garcia-Orellana M; Valentí M; Leza JC; Bernardo M
Span J Psychiatry Ment Health; 2023; 16(3):137-142. PubMed ID: 32674992
[TBL] [Abstract][Full Text] [Related]
36. Effect of Adjunctive Celecoxib on BDNF in Manic Patients Undergoing Electroconvulsive Therapy: a Randomized Double Blind Controlled Trial.
Kargar M; Yoosefi A; Akhondzadeh S; Artonian V; Ashouri A; Ghaeli P
Pharmacopsychiatry; 2015 Nov; 48(7):268-73. PubMed ID: 26398281
[TBL] [Abstract][Full Text] [Related]
37. BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy.
Kleimann A; Kotsiari A; Sperling W; Gröschl M; Heberlein A; Kahl KG; Hillemacher T; Bleich S; Kornhuber J; Frieling H
J Neural Transm (Vienna); 2015 Jun; 122(6):925-8. PubMed ID: 25387785
[TBL] [Abstract][Full Text] [Related]
38. Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only.
Haghighi M; Salehi I; Erfani P; Jahangard L; Bajoghli H; Holsboer-Trachsler E; Brand S
J Psychiatr Res; 2013 Jul; 47(7):908-15. PubMed ID: 23583029
[TBL] [Abstract][Full Text] [Related]
39. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression.
Gedge L; Beaudoin A; Lazowski L; du Toit R; Jokic R; Milev R
Front Psychiatry; 2012; 3():12. PubMed ID: 22375129
[TBL] [Abstract][Full Text] [Related]
40. S100 calcium-binding protein B in older patients with depression treated with electroconvulsive therapy.
Carlier A; Boers K; Veerhuis R; Bouckaert F; Sienaert P; Eikelenboom P; Vandenbulcke M; Stek ML; van Exel E; Dols A; Rhebergen D
Psychoneuroendocrinology; 2019 Dec; 110():104414. PubMed ID: 31493698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
